Non-Hodgkin Lymphoma — Trials

Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

8,120 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,168
Recruiting: 1,127
Ph III recruiting: 115
Growth YoY: +5.7%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%
Trials / 1,000 deaths: 108.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,290)

clinicaltrialsPublishedShowing 151–166 of 166 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00003502	Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma	withdrawn	Phase 2	0	Burzynski Research InstituteOTHER	1	Jul 10, 2013	clinicaltrials
NCT00003505	Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma	withdrawn	Phase 2	0	Burzynski Research InstituteOTHER	1	Jul 10, 2013	clinicaltrials